Education for patients who use an inhaled corticosteroid as a controller medication includes:

Rationale: A. Inhaled corticosteroids function by reducing airway inflammation over time and do not possess the rapid-acting bronchodilatory properties required to reverse acute bronchospasm. Patients must be taught that these are "preventer" medications and will not provide relief during a sudden asthma attack. Relying on a controller during an emergency could lead to respiratory failure if the patient does not use a rescue inhaler. B. Local deposition of corticosteroid particles in the oropharynx can suppress local immunity and alter the normal microflora, leading to Candidiasis or oral thrush. Rinsing the mouth and spitting after each use is a critical preventative measure to remove residual drug from the mucosal surfaces. This simple hygiene step significantly reduces the incidence of painful fungal infections and associated hoarseness or dysphonia. C. Xerostomia and dysgeusia are recognized side effects of many metered-dose and dry-powder inhalers. The propellants or the active steroid molecules can irritate the oral cavity and affect the function of the salivary glands and taste buds. Educating the patient on these possibilities improves therapy adherence by ensuring they understand that these are common, manageable effects rather than a reason to discontinue treatment. D. All of the provided instructions are essential components of a comprehensive asthma or COPD education plan. Each point addresses a specific pharmacological reality of inhaled corticosteroids, from the mechanism of action to the management of local adverse effects. Combining these educational points ensures the patient uses the device safely, effectively, and with a clear understanding of its role in chronic disease management.